• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Catalyst Pharmaceuticals, Inc. (CPRX)

    -NasdaqCM
    3.64 Down 0.02(0.55%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development2,578  2,350  2,384  2,886  
    Selling General and Administrative2,320  1,942  1,600  1,223  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,897) (4,292) (3,984) (4,109)
    Income from Continuing Operations
    Total Other Income/Expenses Net339  (1,118)494  (901)
    Earnings Before Interest And Taxes(4,559)(5,410)(3,490)(5,010)
    Interest Expense -   -   -   -  
    Income Before Tax(4,559)(5,410)(3,490)(5,010)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(4,559)(5,410)(3,490)(5,010)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (4,559) (5,410) (3,490) (5,010)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (4,559) (5,410) (3,490) (5,010)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.